The U.S. Justice Department on Tuesday said it has joined a
whistleblower lawsuit alleging Abbott Laboratories' Alere Inc
unit defrauded Medicare into paying for unnecessary testing
supplies for diabetic patients.
Ohio's attorney general on Tuesday announced he was taking
the first step toward trying to recover nearly $16 million that
he said UnitedHealth Group Inc's pharmacy benefit manager unit
OptumRx overcharged the state for prescription drugs.
North Dakota’s top court is set to consider whether the
state’s cap on noneconomic damages in medical malpractice cases
is constitutional in a lawsuit by a woman who said she had
stroke after undergoing surgery.
A federal appeals court on Friday cleared the way for
UnitedHealth Group Inc to try to block a former executive from
working at the new healthcare venture launched by Amazon.com
Inc, Berkshire Hathaway Inc and JPMorgan Chase.
A federal judge on Friday cleared the way for consumers to
proceed with a proposed class action accusing drug manufacturers
Sanofi SA and Novo Nordisk of fraudulently inflating prices for
A federal appeals court on Thursday cleared the way for the
Democratic-led U.S. House of Representatives to intervene, over
the objections of the Trump administration, in a lawsuit
challenging the constitutionality of the Affordable Care Act.
A New York doctor on Thursday pleaded guilty to accepting
kickbacks from Insys Therapeutics Inc in exchange for
prescribing a potent fentanyl spray called Subsys that is
intended only for treating severe pain in cancer patients.
BOSTON A federal judge weighing whether Harvard University discriminates against Asian-American applicants said on Wednesday both the Ivy League school and a non-profit suing it faced potential problems in proving their positions.
Lawyers for Aveo Pharmaceuticals Inc's former chief
financial officer are fighting the Securities and Exchange
Commission’s request to ban him from ever serving as a corporate
officer again after a jury found he defrauded investors.
Insys Therapeutics Inc's former chief executive said on
Wednesday that the company's founder angrily demanded, over the
objections of another executive, a report showing how much the
drugmaker was profiting from paying doctors who could prescribe
its fentanyl spray Subsys.